A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
Blood Disorders (Hematology)
U-M Pediatrician: Government Missed Opportunity to Improve Care for Children With Sickle Cell Disease
Despite efforts to improve the standard of care for children with sickle cell disease, the nation falls short, says pediatrician
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Despite the proven lifesaving benefit of antibiotics for children with this inherited blood disorder, only 18 percent receive them.
Hundreds of thousands of hospital patients get a pricey genetic test. But it’s often unnecessary, a team of U-M clinicians says.